Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    efc11319
Show Display Options
Rank Status Study
1 Completed
Has Results
Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
Condition: Acute Coronary Syndrome
Interventions: Drug: Lixisenatide (AVE0010);   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.